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Aim of database: The aim of the Danish Hip Arthroplasty Register (DHR) is to continuously 
monitor and improve the quality of treatment of primary and revision total hip arthroplasty 
(THA) in Denmark.
Study population: The DHR is a Danish nationwide arthroplasty register established in 
 January 1995. All Danish orthopedic departments – both public and private – report to the 
register, and registration is compulsory.
Main variables: The main variables in the register include civil registration number, indica-
tion for primary and revision surgery, operation date and side, and postoperative complications. 
Completeness of primary and revision surgery is evaluated annually and validation of a number 
of variables has been carried out.
Descriptive data: A total of 139,525 primary THAs and 22,118 revisions have been registered 
in the DHR between January 1, 1995 and December 31, 2014. Since 1995, completeness of 
procedure registration has been high, being 97.8% and 92.0% in 2014 for primary THAs and 
revisions, respectively. Several risk factors, such as comorbidity, age, specific primary diag-
nosis and fixation types for failure of primary THAs, and postoperative complications, have 
been identified through the DHR. Approximately 9,000 primary THAs and 1,500 revisions are 
reported to the register annually.
Conclusion: The DHR is important for monitoring and improvement of treatment with THA 
and is a valuable tool for research in THA surgery due to the high quality of prospective col-
lected data with long-term follow-up and high completeness. The register can be used for 
population-based epidemiology studies of THA surgery and can be linked to a range of other 
national databases.
Keywords: Danish Hip Arthroplasty Register, validation, completeness
Aim of database
The Danish Hip Arthroplasty Register (DHR) was initiated by the Danish  Orthopedic 
Society in 1994, in cooperation with the Danish Health and Medicine Authority and the 
previous Danish Counties. Data collection began on January 1, 1995. The aim of the 
database is to monitor and improve the quality and outcome of total hip arthroplasty 
(THA) in Denmark by examining the epidemiology of THA surgery, identifying risk 
factors for revision, death, and postoperative complications, estimating implant survival, 
and facilitating improvement of THA surgery and comparison between departments.1
The present paper aimed to describe the organization, content, and quality of DHR 
and thereby illustrate the potential and usefulness of the DHR for monitoring of quality 
and performing clinical epidemiological research.
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Materials and methods
Study population
In the DHR, primary THA is defined as the first implantation 
of a THA. From the beginning of the register, it was decided 
that only data on THA should be included in the register. 
Revision is defined as any later surgical procedure involving 
the primary THA, including change of any component or 
debridement without removal of any part of the  prosthesis. 
Reporting of procedures to the DHR is compulsory for all 
public orthopedic departments and private clinics in  Denmark, 
and the reporting is done by the surgeon immediately after 
surgery. DHR is approved as a national clinical quality data-
base, which according to Danish legislation number 546 from 
June 24, 2005, is allowed to collect surgical and patient related 
data into DHR without consent from the patient.
Upon birth or immigration, all Danish citizens are given 
a unique and unchangeable civil registration number, which 
is recorded for all health care contacts in Denmark. The civil 
registration number allows for linkage between the DHR 
and other national databases. The DHR is linked to the Civil 
Registration System, which holds information on vital status, 
date of migration, or death, thereby allowing for analysis of 
implant survival with complete follow-up.
Main variables
Since the beginning of data collection, variables have been 
changed a number of times to have relevant analyses and results 
for the surgeons. However, the majority of variables – including 
all the main variables – have remained unchanged.
The main preoperative variables include: the civil registration 
number – in which birthday and sex are included –  indication 
for primary procedure, and previous surgery on the hip.
The main perioperative variables for primary and revision 
surgery include: date of surgery, operation side, type of anesthe-
sia, antibiotic prophylactic treatment, surgical approach, duration 
of surgery, type of components and their fixation, and periopera-
tive complications, such as acetabular or femoral fracture.
For revisions, the main variables include: indication for 
revision, previous surgery, extent of surgery, and number of 
previous revisions. Primary THA can be directly linked to any 
subsequent revision by the use of the unique and unchangeable 
civil registration number and registered operation side.
The complete list of the variables in the DHR is shown 
in Table 1.
validation of completeness and coverage
As registration to the DHR is compulsory, the register has 
complete coverage on a national level in principle, but a very 
small number of departments do not report to the register.
Table 1 The main variables in the Danish Hip Arthroplasty Register
Name of the variable Description of the variable
Civil registration number Unique number including age and sex
Type of operation 1. Primary
2. Revision
Operation side 1. Right
2. Left
Previous surgery on hip 1. No
2. Yes
Type of previous surgery 1. Osteosynthesis of proximal femur 
fracture
2. Hemiarthroplasty
3. Osteosynthesis of acetabular fracture
4. Proximal femur osteotomy
5. Total hip arthroplasty
6. Other
Primary diagnosis 1. Osteoarthritis
2–4. Fracture of either femur or 
acetabulum
5. Traumatic dislocation of the hip
6. Avascular necrosis of the femoral head
7–9. Different types of arthritis
10–13. Different types of congenital hip 
disorder
Harris Hip Score Score
Operation date dd.mm.yyyy
Operation theater 1. Laminar flow
2. Conventional
Type of preoperative antibiotics 1. None
2–16. Type of antibiotics
Duration of antibiotic  
treatment
1. Only preoperatively
2. Max. 24 hours
3. .24 hours
Type of anesthesia 1. General
2. Spinal or epidural
3. Combined
4. Other
Anticoagulants 1. None
2. Type
Hemorrhage prophylaxis 1. None
2. Tranexamic acid
3. Other
Duration of surgery Minutes
Approach 1. Posterior
2. Anterior
3. Lateral
4. Other
Acetabular component 1. with holes
2. without holes
Fixation of acetabular  
component
1–7. with/without cement and with/
without screws
Femoral component Type of component
Fixation of femoral component 1–5. with/without cement
Perioperative complication 
acetabulum
1. None
2. Yes
Perioperative complication 
femur
1–6. None, fissure/fracture with/
without osteosynthesis
Femoral head diameter mm
(Continued )
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in the remaining three departments was 58 procedures out 
of 9,830 reported procedures indicating that the involved 
departments are very small.2
Completeness
Completeness has been high from the beginning, with 94% 
for primary THA and 81% for revision in the first 6 years 
of registration.3
On a national level, completeness for primary THA has 
increased to 97.8% in 2014, and completeness for revisions 
has increased to 92.0%, when using the NPR as reference. If 
adjusted for misclassifications in the NPR, where a primary 
THA is registered as a revision due to previous osteosyn-
thesis or hemiarthroplasty, the completeness for revisions 
increases to 96.0%.2
All five regions in Denmark fulfill the requirement of 
90% completeness for primary THAs.
There are very few departments which do not honor the 
demands of 90% completeness of both primary and revision 
THAs.
Analysis of variables
The most common indication is primary osteoarthritis in 
patients who experience pain, reduced level of activity, and 
quality of life accounting for 78% followed by fracture of 
the proximal femur accounting for 12%. In recent years, 
an increasing number of femoral neck fractures have been 
treated with THA.
In all, 96% of THAs are performed through a posterior 
approach. From 1995 to 2004, cemented fixation was most 
commonly used (50%), as compared to hybrid (28%) and 
cementless (22%). However, there has been a shift toward 
the use of more cementless designs, which since 2011 have 
accounted for up to 70% of all primary THAs (Figure 1).
A metal femoral head is the most commonly used (93%). 
In the last 10 years, there has been a trend toward using 
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Figure 1 Type of operation in primary total hip arthroplasty.
Table 1 (Continued )
Name of the variable Description of the variable
Femoral head made of 1. Metal
2. Ceramic
3. Other
Type of liner 1. Polyethylene
2. Ceramic
3. Metal
indication for revision 1–6. Aseptic loosening of one or both 
components with/without osteolysis
7. Osteolysis without loosening
8. Prosthetic joint infection
9. Femoral fracture
10. Dislocation
11. Component failure
12. Pain
13. Other
Previous implant status 1. Cement
2. Cementless
3 and 4. Hybrid
5. Girdlestone
6. Spacer
7. Other
Number of previous revisions Number
Every third month, data in the DHR are analyzed, and 
completeness is assessed using the National Patient Register 
(NPR) as reference. Surgical procedures reported to the NPR 
by departments are reimbursed by the Danish National Health 
and Medicine authorities through the diagnosis-related 
group system which motivates departments for reporting 
to the NPR.
All departments performing either primary or revision 
THAs receive a monthly update on missing registration of 
procedures in the DHR and are requested to report missing 
registration to the DHR. The goal of the DHR is to achieve 
registration completeness of more than 90% for both primary 
and revision THA on a national, regional, and departmental 
level, according to a notification in 2006 on the improvement 
of nationwide and regional clinical quality databases passed 
by the National Board of Health.
Results
The DHR publish an annual report which contains data from 
the year 1995 and onwards, up-dated with data from the previ-
ous year. In the annual report of 2015, 139,525 primary THAs 
and 22,118 revisions have been reported between January 1, 
1995 and December 31, 2014.2 Each year, ∼9,000 primary 
THAs and 1,500 revisions are reported to the register.
Coverage
In 2014, 44 departments performed primary THA, and 41 
of these reported to the DHR. The number of primary THAs 
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larger femoral head sizes, from the 28 mm being the most 
commonly used in 2004 (87%) to a 32 or 36 mm diameter 
representing the majority (85%) in 2014.
The requirement for blood transfusion has decreased 
dramatically from 21.3% in 2006 to 8.5% in 2014. Revi-
sion within 2 years after primary surgery and readmission 
have shown a rather large variation between departments, 
which resulted in a call for an audit in a number of 
departments.
Follow-up
Survival of primary THAs with 18 years follow-up is 
83% (95% confidence interval [CI]: 82%–84%) and with 
10 years follow-up 92% (95% CI: 92%–93%), based on the 
Kaplan–Meier analyses with time to first revision as outcome 
( Figure 2). The most common indication for revision is 
aseptic loosening (53%), followed by dislocation of the hip 
(17%) and prosthetic joint infection (9%).
examples of research
Previous research
Since the beginning in 1995, more than 40 papers have been 
published based on the DHR data linked to other Danish 
medical databases, such as the NPR, the Civil Registration 
System, the Danish Transfusion Database, and the Danish 
Prescription Database. The studies have primarily focused on 
validation of data in the register,3 describing the outcome,4 
and the epidemiology of THA surgery.5,6 A number of risk 
factors for revision have been studied7,8 and so has risk 
for postoperative complications, such as mortality, venous 
thromboembolism, myocardial infarction, and stroke.9,10
Present research
The DHR does not offer financial support for research 
purposes, and research from the register is in most cases 
performed in collaboration with the Department of Clinical 
Epidemiology, Aarhus University Hospital and PhD students 
and cooperation with members of DHR steering committee. 
In 2015, four ongoing PhD students are using data from the 
DHR. They have identified the “true” incidence of prosthetic 
joint infection,11 described the epidemiology and outcome 
of fast track setting in Denmark,12 found that ceramic-on-
ceramic does not have a greater risk of revision compared to 
metal-on-polyethylene bearings,13 and identified cirrhosis as 
a risk factor for postoperative complications.14
Administrative issues and funding
The steering committee of the DHR consists of an orthopedic 
surgeon from each of the five Danish Regions, a representa-
tive from the Danish Society for Hip and Knee Arthroplasty 
and the Danish Orthopedic Society, a representative for the 
Competence Centre North, Department of Clinical Epidemi-
ology, Aarhus University Hospital, and a representative for 
Central Denmark Region. All research protocols, in which 
data from the DHR are used, must be approved by the steering 
committee before an initiation of a project.
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Figure 2 Surveillance graph of all primary total hip arthroplasties (n=139,295).
Abbreviation: CI, confidence interval.
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The Danish Hip Arthroplasty Register
The DHR publishes an annual report, which is distrib-
uted to all Regions, Danish Health and Medicines Authority, 
all participating departments, and the Danish Orthopaedic 
Society. The results are presented at the Annual Congress of 
the Danish Orthopaedic Society. The DHR shares the budget 
with the three other orthopedic databases included in the 
Danish Common Orthopedic Database, which has an annual 
budget of ∼1.2 million Danish kroner (€160,000), received 
from the Danish Regions.
Cooperation with other databases
The DHR cooperates with the Nordic Arthroplasty Register 
Association.15 The collaboration started in 2008 among the 
DHR, the Swedish Hip and Knee Arthroplasty Register, and 
the Norwegian Arthroplasty Register. The Finnish Arthro-
plasty Register joined in 2010. Besides comparison of national 
difference in patient demographics, operation methods, and 
choice of implant, this register association offers a high 
 volume of primary THA and revision data. Seventeen papers 
have been published using data from the register.
Conclusion
The DHR is important for the monitoring of treatment with 
THA as the register holds prospective collected validated data 
with a long-term follow-up and high completeness. The DHR 
can be linked to a wide range of other national databases, 
and therefore the register is a valuable tool for research of 
THA surgery and quality improvement. Data from the DHR 
have been used to describe the epidemiology and trends in 
THA surgery, and identify risk factors for revision, death, 
and postoperative complications.
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